About Index Trending news
Analyze
Pricing
Brainvectis

Brainvectis

Brainvectis

BrainVectis's goal is to stop the progression of neurodegenerative diseases such as Alzheimer's and Huntington's by restoring brain cholesterol metabolism..

Elsewhere

Alexa global traffic share

Latest funding
Venture capital (Series A)
€1,000,000
Employees

Unknown size

Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Brainvectis makes some noise.